feed,title,long_url,short_url
Benzinga,"Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst",https://benzinga.com/analyst-ratings/analyst-color/24/02/37077499/gene-therapy-player-regenxbios-rgx-121-marks-success-in-trial-yet-faces-challenges-,https://da.gd/MB267
Benzinga,$100 Invested In Crown Castle 20 Years Ago Would Be Worth This Much Today,https://benzinga.com/insights/news/24/02/37077333/100-invested-in-crown-castle-20-years-ago-would-be-worth-this-much-today,https://da.gd/cBX3Q
Benzinga,$100 Invested In Snap-on 20 Years Ago Would Be Worth This Much Today,https://benzinga.com/insights/news/24/02/37077330/100-invested-in-snap-on-20-years-ago-would-be-worth-this-much-today,https://da.gd/QwsZAg
